CILcare is pleased to announce the appointment of Dr. Wahid AWAD as Chief Business Officer. Dr. Awad will continue to lead all avenues of CILcare’ s global business operations. As a member of the board of directors, he will be helping in establishing long-term goals, strategies and plans for the company.
“Humbled and honoured, I’m excited to take on more responsibilities and to lead the business department to develop and implement business strategies that enhance CILcare’s position as a world leading and a unique one-stop-shop partner for external innovations in the field of hearing disorders. I’m very passionate about being part of the effort to help pharma, biotech, MedTech and academic institutes to accelerate the development of solutions to prevent or cure hearing disorders (hearing loss, tinnitus, otitis and ototoxicity).This will help to improve the quality of life of more than 466 million people (34 million of these being children) with disabling hearing loss” said Dr. Awad.
“CILcare is developing, as well as our team. Wahid is a natural leader; he has a vision for CILcare and ambitious objectives for the next development phases. In his new role as Chief Business Officer, Wahid, with his team, will help CILcare take a step further, developing stronger client relationships, building strategic alliances, expanding CILcare’s service offering and continuing to make hearing a priority.” added Celia Belline, CEO.
Dr. Awad joined CILcare as Business Development Manager and has taken on positions of increasing responsibility, most recently serving as Director of Business Strategy and Alliances since May 2019. During his tenure, he played a leading role in managing business development, building strategic partnerships and alliances, and identifying promising opportunities and channels for CILcare’s growth.